Imatron sells HeartScan-Pittsburgh Center

Article

Ultrafast CT developer Imatron sold another of its U.S. HeartScan coronary artery disease risk assessment centers last month, this one to the University of Pittsburgh Medical Center. The June 17 deal transferred HeartScan-Pittsburgh operations to the

Ultrafast CT developer Imatron sold another of its U.S. HeartScan coronary artery disease risk assessment centers last month, this one to the University of Pittsburgh Medical Center. The June 17 deal transferred HeartScan-Pittsburgh operations to the University of Pittsburgh’s Cardiovascular Institute, which plans to start a preventive heart care center using Imatron’s electron beam CT unit.

With its divestiture of HeartScan-Pittsburgh, South San Francisco, CA-based Imatron comes closer to its goal of focusing its efforts on marketing its ultrafast CT units, according to Lewis Meyer, CEO. The company has been seeking individual buyers for each of its centers since earlier this year, after an initial effort to sell all four centers to one buyer failed.

In February, the company sold its South San Francisco facility to Imaging Technology Group, also of South San Francisco, and a month later found a potential buyer for its Houston and Washington, DC centers in Vital Imaging Companies of Newport Beach, CA (SCAN 3/31/99 and 3/17/99). But the Vital Imaging deal fell through due to lack of financing, so Imatron continues to seek a buyer for the two centers, company executives said.

In other Imatron news, the company sold two Ultrafast CT scanners in late June, one to a German hospital and the other to a San Diego facility. The San Diego sale was financed by GE Capital under the terms of a marketing arrangement between Imatron and GE Medical Systems of Milwaukee (SCAN 6/24/98).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.